Benzinga | May 6, 2021 04:01PM EDT

Cytokinetics Q1 EPS $(0.66) Misses $(0.58) Estimate, Sales $6.55M Miss $6.58M Estimate

Cytokinetics (NASDAQ:CYTK) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimate of $(0.58) by 13.79 percent. This is unchanged from the same period last year. The company reported quarterly sales of $6.55 million which missed the analyst consensus estimate of $6.58 million by 0.49 percent. This is a 71.19 percent increase over sales of $3.83 million the same period last year.